James R. Downing, MD

Dr. James R. Downing details how St. Jude strategic plan expansion aims to accelerate research and treatment for childhood catastrophic diseases.

St. Jude Children’s Research Hospital is launching the largest strategic investment in its nearly 60-year history, committing $11.5 billion during the next six years to accelerate research and treatment globally for children with catastrophic diseases.

Read about the work from a goal – to a treatment – to a cure – and one scientist’s legacy.

Germline mutations can contribute to leukemia, retinoblastoma, and other pediatric cancers. Learn about advancements in the first landmark effort specifically designed to better understand these mutations and develop novel treatment methods.

Find out what makes St. Jude Children’s Research Hospital the best pediatric cancer hospital in the nation.

To honor our past and future, St. Jude dedicates the Donald Pinkel, MD, Research Tower to recognize the institution’s first president and director.